Statistics
Publications
6
Citations
818
H-Index
6
Active since
1974
Affiliations
Impact Assessment(Current)
Tori Lin is an author at Impact Assessment specializing in pharmacology, nicotinamide phosphoribosyltransferase, and nicotinic acid phosphoribosyltransferase.
Publications per year
1974–2019
6
6
Effect of selective LRRK2 kinase inhibition on nonhuman primate lung
Reina N. Fuji, Michael Flagella, Miriam Baca et al. · Science Translational Medicine · 2015 · 370 citations
Pharmacy, Pharmacology, Toxicology +13
Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer
WeiYu Lin, Daqi Xu, Cary D. Austin et al. · Frontiers in Immunology · 2019 · 201 citations · Full text
A 99mTc-chelate substitute for organoradiomercurial renal agents.
Tori Lin, Archie Khentigan, H. S. Winchell · PubMed · 1974 · 106 citations
1–5 of 6